Pherecydes Pharma changes its Corporate Governance and appoints Didier Hoch as CEO and Chairman of its first Board of Directors

– FRANCE, Nantes –  Pherecydes Pharma (EPA: ALPHE), a biotech company specializing in precision phage therapy for the treatment of resistant and/or complicated bacterial infections, today announced the appointment of previous Chairman of its Supervisory Board Didier Hoch as Chairman of the Board of Directors and CEO, effective on May 19, 2022, alongside previous members of the Supervisory Board who were appointed as the first directors of Pherecydes Pharma.…